shadow_tr


Study Finder

Tulane Cancer Center Research > Office of Clinical Research > Clinical Trials Study Finder > Hematopoietic Failure & Genetic Diseases Transplant Studies

Hematopoietic Failure & Genetic Diseases Transplant
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

BMT 2001-01
G-CSF Primed Donor Leukocyte Infusion (G-DLI) for Treatment of Relapsed Hematologic Malignancy After Allogeneic Stem Cell Transplant

BMT 2001-03
Phase II Trial of CD34 Selected Peripheral Blood Progenitor Cells with Immunoablation in the Treatment of Severe Autoimmune Disease

INCB 18424-258
An Open Label Assessment of Safety and Efficacy of Ruxolitinib (INCB018424) in Subjects With Primary Myelofibrosis, Post Essential Thrombocythemiamyelofibrosis and Post Polycythemia Vermayelofibrosis Who Have Platelet Counts of 50 x 109/L to 100 x 109/L
More Information



 

 

 

1430 Tulane Ave, New Orleans, LA 70112 504-988-5263 medsch@tulane.edu